Cryolife Inc - Initial Statement of Beneficial Ownership

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2008 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Capps Scott B

2. Date of Event Requiring Statement (MM/DD/YYYY) 10/29/2007

3. Issuer Name and Ticker or Trading Symbol

CRYOLIFE INC [CRY]

(Last) (First) (Middle)

CRYOLIFE, INC., 1655 ROBERTS BLVD., NW

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
VP-Clinical Research /

(Street)

KENNESAW, GA 30144

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7047 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	8/31/2003 ⁽²⁾	2/29/2008	Common Stock	11750	$2.20	D
Stock Option	9/30/2005 ⁽³⁾	7/24/2010	Common Stock	20000	$7.06	D
Stock Option	1/19/2008 ⁽⁴⁾	7/19/2012	Common Stock	1500	$7.875	D
Stock Option	8/2/2008 ⁽⁵⁾	8/2/2014	Common Stock	25000	$9.06	D

Explanation of Responses:
( 1)	Represents 5,000 shares of restricted stock that vest on the third anniversary of the grant date (which was July 30, 2007) if the reporting person remains in the continuous employ of the Company.
( 2)	Stock option vests in 20% increments beginning on first anniversary of grant date (which was August 31, 2002).
( 3)	Stock option was granted on January 24, 2005. Stock option became fully vested by Board action on September 30, 2005.
( 4)	Stock option vests in 20% increments beginning on first anniversary of grant date (which was January 19, 2007).
( 5)	Stock option vests in 1/3 increments beginning on first anniversary of grant date (which was August 2, 2007).

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Capps Scott B CRYOLIFE, INC. 1655 ROBERTS BLVD., NW KENNESAW, GA 30144			VP-Clinical Research

Signatures
/s/ Scott B. Capps		10/29/2007
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.